Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasal High Flow (NHF) Therapy Use Following Hospitalization for an Exacerbation of COPD: A Feasibility Study

NCT02552732 is registered in ClinicalTrials.gov with Fisher and Paykel Healthcare as lead sponsor.

NCT NCT02552732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02552732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasal High Flow (NHF) Therapy Use Following Hospitalization for an Exacerbation of COPD: A Feasibility Study
Lead sponsor
Fisher and Paykel Healthcare
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2015
Completion date
May 3, 2017
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, copd